School of Medicine
Gastrointestinal Oncology Program
Area of interest
Dr. Robert Sandler is an internist/gastroenterologist with research interests in colon cancer etiology, screening and prevention, and intermediate markers of colon cancer risk. He is the principal investigator of the North Carolina Colon Cancer Study, a population-based, case-control study exploring environmental, lifestyle and medical factors that might explain diverging black-white incidence and mortality trends for colorectal cancer. He is principal investigator for an NCI-funded investigation to study rectal mucosal proliferation and recently served as study chair of a multicenter chemoprevention clinical trial testing whether aspirin can prevent colorectal adenomas in patients who have undergone curative resection for e colorectal cancer. He is the principal investigator for the North Carolina Colorectal Cancer Care Outcomes Research and Surveillance (CanCORS) study, an NCI initiative to investigate the impact of processes of cancer care on outcomes. He is also an investigator for multicenter cooperative trials of calcium and aspirin/folate prevention of neoplastic polyps. He directs an NIH-funded training grant in digestive disease epidemiology and the NIH-funded UNC Center for Gastrointestinal Biology and Disease. He is the president of the American Gastroenterological Association and was a member of the National Commission on Digestive Diseases.
Awards and Honors
Named visiting professor at: University of Washington, Northwestern University, Harvard Medical School, Yale University School of Medicine. University of Chicago, Massachusetts General Hospital, Vanderbilt
President, American Gastroenterological Association Institute, 2008-9.
Masters Award for Sustained Achievement in Digestive Disease, May 2006
Best Doctors: 2005-2009
National Commission on Digestive Diseases 2008